Monopar Therapeutics MNPR Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Monopar Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.
The official record: Monopar Therapeutics’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Monopar Therapeutics's net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Monopar Therapeutics's net change in cash?
- Monopar Therapeutics (MNPR) reported net change in cash of -$9.29M in Q1 2026.
- How has Monopar Therapeutics's net change in cash changed year-over-year?
- Monopar Therapeutics's net change in cash decreased by 52.2% year-over-year, from -$6.1M to -$9.29M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.